Skip to main content
SpringerLink
Log in

Diacerein as a disease-modulating agent in osteoarthritis

  • Published:
Current Rheumatology Reports Aims and scope Submit manuscript

Abstract

This paper reviews the most recent clinical and experimental studies on diacerein, both of which are under investigation. Diacerein could be a disease-modulating agent in osteoarthritis because structural benefits have been reported in recent trials. Moreover, after an empirical use, studies return to the experimental field to understand the mechanism of action of this molecule. However, clinical trials using new sets of criteria could be conducted to estimate the structural modulating effect of diacerein; experimental studies must be performed to understand this effect.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References and Recommended Reading

  1. Martel-Pelletier J, Mineau F, Jolicoeur FC, Cloutier JM, Pelletier JP: In vitro effects of diacerhein and rhein on interleukin 1 and tumor necrosis factor-alpha systems in human osteoarthritic synovium and chondrocytes. J Rheumatol 1998, 25:753–762.

    PubMed  CAS  Google Scholar 

  2. Yaron M, Shirazi I, Yaron I: Anti-interleukin-1 effects of diacerein and rhein in human osteoarthritic synovial tissue and cartilage cultures. Osteoarthritis Cartilage 1999, 7:272–280.

    Article  PubMed  CAS  Google Scholar 

  3. Moore AR, Greenslade KJ, Alam CA, Willoughby DA: Effects of diacerhein on granuloma induced cartilage breakdown in the mouse. Osteoarthritis Cartilage 1998, 6:19–23.

    Article  PubMed  CAS  Google Scholar 

  4. Smith GN Jr, Myers SL, Brandt KD, Mickler EA, Albrecht ME:Diacerhein treatment reduces the severity of osteoarthritis in the canine cruciate-deficiency model of osteoarthritis. Arthritis Rheum 1999, 42:545–554.

    Article  PubMed  CAS  Google Scholar 

  5. Mazieres B, Berdah L, Thiechart M, Viguier G: Diacetylrhein on a postcontusion model of experimental osteoarthritis in the rabbit. Rev Rhum Ed Fr 1993, 60:77S-81S.

    PubMed  CAS  Google Scholar 

  6. Boittin M, Redini F, Loyau G, and Pujol JP: Effect of diacerhein (ART 50) on the matrix synthesis and collagenase secretion by cultured joint chondrocytes in rabbits. Rev Rhum Ed Fr 1993, 60:68S-76S.

    PubMed  CAS  Google Scholar 

  7. Felisaz N, Boumediene K, Ghayor C, et al.: Stimulating effect of diacerein on TGF-beta1 and beta2 expression in articular chondrocytes cultured with and without interleukin-1. Osteoarthritis Cartilage 1999, 7:255–264.

    Article  PubMed  CAS  Google Scholar 

  8. Hwa SY, Burkhardt D, Little C, Ghosh P: The effects of orally administered diacerein on cartilage and subchondral bone in an ovine model of osteoarthritis. J Rheumatol 2001, 28:825–834.

    PubMed  CAS  Google Scholar 

  9. Burkhardt D, Hwa SY, Ghosh P: A novel microassay for the quantitation of the sulfated glycosaminoglycan content of histological sections: its application to determine the effects of Diacerhein on cartilage in an ovine model of osteoarthritis. Osteoarthritis Cartilage 2001, 9:238–247.

    Article  PubMed  CAS  Google Scholar 

  10. Puustjarvi K, Lammi M, Kiviranta I, Helminen HJ, Tammi M:Proteoglycan synthesis in canine intervertebral discs after long-distance running training. J Orthop Res 1993, 11:738–746.

    Article  PubMed  CAS  Google Scholar 

  11. Kiviranta I, Jurvelin J, Tammi M, Saamanen AM, Helminen HJ:Microspectrophotometric quantitation of glycosaminoglycans in articular cartilage sections stained with Safranin O. Histochemistry 1985, 82:249–255.

    Article  PubMed  CAS  Google Scholar 

  12. Pelletier JP, Lajeunesse D, Reboul P, et al.: Diacerein reduces the excess synthesis of bone remodeling factors by human osteoblast cells from osteoarthritic subchondral bone. J Rheumatol 2001, 28:814–824. Primary subchondral osteoblast cell cultures collected in femoral condyles of patients undergoing knee replacement used for assays on subchondral bone metabolism.

    PubMed  CAS  Google Scholar 

  13. Onodera S, Suzuki K, Kaneda K, Fujinaga M, Nishihira J:Growth factor-induced expression of macrophage migration inhibitory factor in osteoblasts: relevance to the plasminogen activator system. Semin Thromb Hemost 1999, 25:563–568.

    Article  PubMed  CAS  Google Scholar 

  14. Hilal G, Martel-Pelletier J, Pelletier JP, Ranger P, Lajeunesse D:Osteoblast-like cells from human subchondral osteoarthritic bone demonstrate an altered phenotype in vitro: possible role in subchondral bone sclerosis. Arthritis Rheum 1998, 41:891–899.

    Article  PubMed  CAS  Google Scholar 

  15. Harbeck N, Kruger A, Sinz S, et al.: Clinical relevance of the plasminogen activator inhibitor type1—a multifaceted proteolytic factor. Onkologie 2001, 24:238–244.

    Article  PubMed  CAS  Google Scholar 

  16. Tamura T, Kosaka N, Ishiwa J, et al.: Rhein, an active metabolite of diacerein, down-regulates the production of promatrix metalloproteinases-1, -3, -9 and -13 and up-regulates the production of tissue inhibitor of metalloproteinase-1 in cultured rabbit articular chondrocytes. Osteoarthritis Cartilage 2001, 9:257–263. A work on rabbit chondrocyte 2D cultures in which active metabolite of diacerein is shown to suppress matrix metalloproteinase (MMP) production.

    Article  PubMed  CAS  Google Scholar 

  17. Tamura T, Ohmori K: Rhein, an active metabolite of diacerein, suppresses the interleukin-1alpha-induced proteoglycan degradation in cultured rabbit articular chondrocytes. Jpn J Pharmacol 2001, 85:101–104.

    Article  PubMed  CAS  Google Scholar 

  18. Tamura T, Ohmori K: Diacerein suppresses the increase in plasma nitric oxide in rat adjuvant-induced arthritis. Eur J Pharmacol 2001, 419:269–274. Successful treatment of the rat adjuvant-induced arthritis model.

    Article  PubMed  CAS  Google Scholar 

  19. Pietrangelo A, Montosi G, Recalcati S, Garuti C, Cairo G:Diacerhein blocks iron regulatory protein activation in inflamed human monocytes. Life Sci 1998, 63:L213–219.

    Article  Google Scholar 

  20. Cruz TF, Tang J, Pronost S, Pujol JP: [Molecular mechanisms implicated in the inhibition of collagenase expression by diacerheine]. Rev Prat 1996, 46:S15-S19.

    PubMed  CAS  Google Scholar 

  21. Pelletier JP, Yaron M, Haraoui B, et al.: Efficacy and safety of diacerein in osteoarthritis of the knee. Arthritis Rheum 2000, 43:2339–2348. This dose ranging study concluded that 100 mg is probably the optimal dose to improve the symptoms of knee osteoarthritis.

    Article  PubMed  CAS  Google Scholar 

  22. Dougados M, Nguyen M, Berdah L, et al., for the ECHODIAH Investigators Study Group: Evaluation of the structuremodifying effects of diacerein in hip osteoarthritis: ECHODIAH, a 3-year placebo-controlled trial. Arthritis Rheum 2001, In press. This 3-year placebo-controlled trial in 507 patients with painful hip osteoarthritis suggested that, besides its previously demonstrated symptomatic effect, diacerein may have a beneficial structural effect.

  23. Pelletier JP, Mineau F, Fernandes JC, Duval N, Martel-Pelletier J:Diacerhein and rhein reduce the interleukin-1 beta stimulated inductible nitric oxide synthesis level and activity while stimulating cyclooxygenase-2 synthesis in human osteoarthritic chondrocytes. J Rheumatol 1998, 25:2417–2424.

    PubMed  CAS  Google Scholar 

  24. Nguyen M, Dougados M, Berdah L, Amor B: Diacerhein in the treatment of osteoarthritis of the hip. Arthritis Rheum 1994, 37:529–536.

    Article  PubMed  CAS  Google Scholar 

  25. Lequesne M, Berdah L, Gerentes I: Efficacy and tolerance of diacerhein in the treatment of gonarthrosis and coxarthrosis. Rev Prat 1998, 48:31–35.

    Google Scholar 

  26. Leng-Peschlow E: Effect of sennosides and related compounds on intestinal transit in the rat. Pharmacology 1988, 36:40–48.

    Article  PubMed  CAS  Google Scholar 

  27. Yagi T, Miyawaki Y, Nishikawa T, Yamauchi K, Kuwano S:Involvement of prostaglandin E-like material in the purgative action of rhein anthrone, the intraluminal active metabolite of sennosides A and B in mice. J Pharm Pharmacol 1988, 40:27–30.

    PubMed  CAS  Google Scholar 

  28. Maillefert JF, Gueguen A, Nguyen M, et al.: Relevant change in radiological progression in patients with hip osteoarthritis, I: Determination using predictive validity for total hip arthroplasty. Rheumatology 2001, In press.

  29. Maillefert JF, Nguyen M, Gueguen A, et al.: Relevant change in radiological progression in patients with hip osteoarthritis, II: Determination using predictive validity for total hip arthroplasty. Rheumatology 2001, In press.

  30. van der Heijde D, Lassere M, Edmonds J, et al.: Minimal clinically important difference in plain films in RA: group discussions, conclusions and recommendations. OMERACT Imaging Task Force. J Rheumatol 2001, 28:914–917.

    PubMed  Google Scholar 

  31. Dougados M, Gueguen A, Nguyen M, et al.: Radiographic features predictive of radiographic progression of hip osteoarthritis. Rev Rhum 1997, 64:795–803.

    CAS  Google Scholar 

  32. Maillefert JF, Sharp JT, Aho JS, Dougados M: Evaluation of two methods assessing radiographic joint space width in hip osteoarthritis. Arthritis Rheum 2001, In press.

Download references

Author information

Authors and Affiliations

  1. Rheumatology B Department, René Descartes University, Cochin Hospital, 27 rue du Faubourg Saint Jacques, 75014, Paris, France

    Géraldine Falgarone MD & Maxime Dougados MD

Authors
  1. Géraldine Falgarone MD
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Maxime Dougados MD
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

About this article

Cite this article

Falgarone, G., Dougados, M. Diacerein as a disease-modulating agent in osteoarthritis. Curr Rheumatol Rep 3, 479–483 (2001). https://doi.org/10.1007/s11926-001-0061-y

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1007/s11926-001-0061-y

Keywords

Search

Navigation